GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (STU:81X) » Definitions » Quick Ratio

LifeTech Scientific (STU:81X) Quick Ratio : 2.02 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LifeTech Scientific Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. LifeTech Scientific's quick ratio for the quarter that ended in Jun. 2024 was 2.02.

LifeTech Scientific has a quick ratio of 2.02. It generally indicates good short-term financial strength.

The historical rank and industry rank for LifeTech Scientific's Quick Ratio or its related term are showing as below:

STU:81X' s Quick Ratio Range Over the Past 10 Years
Min: 1.13   Med: 3.01   Max: 5.98
Current: 2.02

During the past 13 years, LifeTech Scientific's highest Quick Ratio was 5.98. The lowest was 1.13. And the median was 3.01.

STU:81X's Quick Ratio is ranked better than
51.26% of 872 companies
in the Medical Devices & Instruments industry
Industry Median: 1.925 vs STU:81X: 2.02

LifeTech Scientific Quick Ratio Historical Data

The historical data trend for LifeTech Scientific's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Quick Ratio Chart

LifeTech Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 2.93 3.54 1.98 2.27

LifeTech Scientific Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.46 1.98 2.51 2.27 2.02

Competitive Comparison of LifeTech Scientific's Quick Ratio

For the Medical Devices subindustry, LifeTech Scientific's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific's Quick Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Quick Ratio distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's Quick Ratio falls into.


';

LifeTech Scientific Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

LifeTech Scientific's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(286.541-62.108)/98.907
=2.27

LifeTech Scientific's Quick Ratio for the quarter that ended in Jun. 2024 is calculated as

Quick Ratio (Q: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(284.105-70.374)/105.84
=2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeTech Scientific  (STU:81X) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


LifeTech Scientific Quick Ratio Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

LifeTech Scientific Headlines

No Headlines